Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion.

Simple Summary: Cancer immune evasion poses a significant challenge in developing effective cancer treatments. The interplay between the immune system and tumors influences cancer growth at various stages. While traditional treatments like surgery, radiation, chemotherapy, and targeted drugs remain fundamental, the emergence of immunotherapy has revolutionized cancer care. Harnessing the body's immune system, immunotherapy significantly improves patient outcomes, prompting efforts to enhance treatment efficacy. This review explores recent advancements in understanding cancer immune evasion mechanisms and evaluates various immunotherapy approaches, including cancer vaccines, adoptive cell therapy, and antibody-based treatments. It covers a broad spectrum of treatments, from established ones to those still under investigation, offering important insights for developing new anticancer immunotherapies. By analyzing resistance mechanisms, exploring combination strategies, and employing personalized approaches, the review aims to illuminate pathways for more effective treatments. Overall, this review aims to summarize recent developments in cancer immunology and immunotherapy, detailing new insights into cancer immune evasion mechanisms for identifying novel treatments. Cancer immune evasion represents a leading hallmark of cancer, posing a significant obstacle to the development of successful anticancer therapies. However, the landscape of cancer treatment has significantly evolved, transitioning into the era of immunotherapy from conventional methods such as surgical resection, radiotherapy, chemotherapy, and targeted drug therapy. Immunotherapy has emerged as a pivotal component in cancer treatment, harnessing the body's immune system to combat cancer and offering improved prognostic outcomes for numerous patients. The remarkable success of immunotherapy has spurred significant efforts to enhance the clinical efficacy of existing agents and strategies. Several immunotherapeutic approaches have received approval for targeted cancer treatments, while others are currently in preclinical and clinical trials. This review explores recent progress in unraveling the mechanisms of cancer immune evasion and evaluates the clinical effectiveness of diverse immunotherapy strategies, including cancer vaccines, adoptive cell therapy, and antibody-based treatments. It encompasses both established treatments and those currently under investigation, providing a comprehensive overview of efforts to combat cancer through immunological approaches. Additionally, the article emphasizes the current developments, limitations, and challenges in cancer immunotherapy. Furthermore, by integrating analyses of cancer immunotherapy resistance mechanisms and exploring combination strategies and personalized approaches, it offers valuable insights crucial for the development of novel anticancer immunotherapeutic strategies. [ABSTRACT FROM AUTHOR]

Copyright of Biology (2079-7737) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)